Related Experiment Video
Updated: Aug 12, 2026

Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran
Published on: November 18, 2022
Association of diet with intestinal permeability and inflammation markers in patients with type 1 diabetes
Sofija Ivanova1, Aleksejs Fedulovs1, Kaspars Jēkabsons1
1Faculty of Medicine and Life Sciences, University of Latvia, LV-1004 Riga, Latvia.
Abstract:
Nutrition can affect gut dysbiosis and low-grade inflammation in type 1 diabetes (T1D). The present cross-sectional study aimed to explore the association between dietary factors and inflammatory and endotoxemia markers in patients with T1D. Participants completed a 24-h dietary recall, a 3-day food record and a food frequency questionnaire, and serum levels of inflammatory and endotoxemia markers, and fecal calprotectin levels were measured. In the T1D group, higher high-sensitivity C-reactive protein levels were associated with a higher intake of hot drinks (such as coffee, tea and cocoa) [OR, 3.95 (95% CI, 1.41-11.08), P=0.009] and legumes [OR, 4.91 (95% CI,1.38-17.41), P=0.014], and a lower intake of protein [OR, 0.27 (95% CI, 0.08-0.87), P=0.028], fat [OR, 0.29 (95% CI, 0.09-0.93), P=0.037], energy [OR, 0.26 (95% CI, 0.09-0.77), P=0.015] and fiber [OR, 0.34 (95% CI, 0.12-0.99), P=0.047]. Higher lipopolysaccharide (LPS) levels [OR, 2.07 (95% CI, 1.17-8.02), P=0.022]) and LPS/high-density lipoprotein ratio [OR, 2.71 (95% CI, 1.06-6.95), P=0.038] were associated with an increased consumption of red meat. In addition, fecal calprotectin levels were positively associated with higher protein consumption [OR, 3.37 (95% CI, 1.14-9.95), P=0.028]. In conclusion, the present exploratory study identified several associations between dietary choices and markers of intestinal permeability and inflammation in T1D, highlighting the need for further intervention studies investigating intestinal permeability.
More Related Videos
07:32An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance
Published on: December 3, 2020
09:24Functional Assessment of Intestinal Permeability and Neutrophil Transepithelial Migration in Mice using a Standardized Intestinal Loop Model
Published on: February 11, 2021
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis
Dysbiosis of the Gut Microbiota
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...